Search research articles
Contact Us
Filters
Showing results (171-180 of 202) with videos related to
Page
of 21
Sort By:
The Journal of Urology
|
February 22, 2011
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy
Guru Sonpavde, Myrna M Khan, Robert S Svatek, et al.
Urology
|
February 4, 2014
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis
Jamie C Messer, Shahrokh F Shariat, Colin P Dinney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Max Kates, Andres Matoso, Woonyoung Choi, et al.
World Journal of Urology
|
October 20, 2011
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
Thomas F Chromecki, Julian Mauermann, Eugene K Cha, et al.
BJU International
|
February 6, 2010
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
Shahrokh F Shariat, Robert S Svatek, Derya Tilki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study
Jean-Jacques Patard, Hyung L Kim, John S Lam, et al.
Molecular Therapy Oncolytics
|
July 18, 2022
Lentiviral interferon: A novel method for gene therapy in bladder cancer
Sharada Mokkapati, Vikram M Narayan, Ganiraju C Manyam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer
Anita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
European Urology
|
June 20, 2015
Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]
Hans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 202) with videos related to
Sort By:
Page
of 21
The Journal of Urology
|
February 22, 2011
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy
Guru Sonpavde, Myrna M Khan, Robert S Svatek, et al.
Urology
|
February 4, 2014
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis
Jamie C Messer, Shahrokh F Shariat, Colin P Dinney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Max Kates, Andres Matoso, Woonyoung Choi, et al.
World Journal of Urology
|
October 20, 2011
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
Thomas F Chromecki, Julian Mauermann, Eugene K Cha, et al.
BJU International
|
February 6, 2010
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
Shahrokh F Shariat, Robert S Svatek, Derya Tilki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study
Jean-Jacques Patard, Hyung L Kim, John S Lam, et al.
Molecular Therapy Oncolytics
|
July 18, 2022
Lentiviral interferon: A novel method for gene therapy in bladder cancer
Sharada Mokkapati, Vikram M Narayan, Ganiraju C Manyam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer
Anita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
European Urology
|
June 20, 2015
Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]
Hans-Martin Fritsche, Maximilian Burger, Robert S Svatek, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Page
of 21